Urinary isothiocyanate levels, Brassica, and human breast cancer

Cancer Research

Volumn 63, Issue 14, 2003, Pages 3980-3986

  Fowke, Jay H ^a,d   Chung, Fung Lung ^b   Jin, Fan ^c   Qi, Dai ^a   Cai, Qiuyin ^a   Conaway, Cliff ^b   Cheng, Jia Rong ^c   Shu, Xiao Ou ^a   Gao, Yu Tang ^c   Zheng, Wei ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b AMERICAN HEALTH FOUNDATION   (United States)

^c FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; GLUCOSINOLATE; GLUTATHIONE TRANSFERASE; ISOTHIOCYANIC ACID; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; STEROID HORMONE;

ADULT; APOPTOSIS; ARTICLE; BRASSICA; BREAST CANCER; CABBAGE; CANCER INCIDENCE; CANCER RISK; CELL PROLIFERATION; CHINA; CONTROLLED STUDY; FEMALE; HORMONE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; URINALYSIS;

ADULT; BRASSICA; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; ISOTHIOCYANATES; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE);

EID: 0042674326     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. World Cancer Research Fund Food, Nutrition and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, 1997.
2. Fahey, J. W., Zalcmann, A. T., and Talalay, P. The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochemistry, 56: 5-51, 2001.
3. Nugon-Baudon, L., Rabot, S., Flinois, J-P., Lory, S., and Beaune, P. Effects of the bacterial status of rats on the changes in some liver cytochrome P450 (EC1.14.14.1) apoproteins consequent to a glucosinolate-rich diet. Br. J. Nutr., 80: 231-234, 1998.
4. Grubbs, C. J., Steele, V. E., Casebolt, T., Juliana, M. M., Eto, I., Whitaker, L. M., Dragnev, K. H., Kelloff, G. J., and Lubet, R. L. Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res., 15: 709-716, 1995.
5. Nakagawa, H., Tsuta, K., Kiuchi, K., Senzaki, H., Tanaka, K., Hioki, K., and Tsubura, A. Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines. Carcinogenesis (Lond.), 22: 891-897, 2001.
6. Wattenberg, L. W. Inhibition of carcinogen-induced neoplasia by sodium cyanate, tert-butyl isocyanate, and benzyl isothiocyanate administered subsequent to carcinogen exposure. Cancer Res., 41: 2991-2994, 1981.
7. Bresnick, E., Birt, D. F., Wolterman, K., Wheeler, M., and Markin, R. S. Reduction in mammary tumorigenesis in the rat by cabbage and cabbage residue. Carcinogenesis (Lond.), 11: 1159-1163, 1990.
8. Stoewsand, G. S., Anderson, J. L., and Munson, L. Protective effect of dietary brussels sprouts against mammary carcinogenesis in sprague-dawley rats. Cancer Lett., 39: 199-207, 1988.
9. Bogaards, J. J., Verhagen, H., Willems, M., van Poppel, G., and van Bladeren, P. J. Consumption of brussels sprouts results in elevated alpha-class glutathione s-transferase levels in human blood plasma. Carcinogenesis (Lond.), 15: 1073-1075, 1994.
10. Kirlin, W. G., Cai, J., DeLong, M. J., Patten, E. J., and Jones, D. P. Dietary compounds that induce cancer preventive phase 2 enzymes activate apoptosis at comparable doses in HT29 colon carcinoma cells. J. Nutr., 129: 1827-1835, 1999.
11. Prochaska, H. J., Santamaria, A. B., and Talalay, P. Rapid detection of inducers of enzymes that protect against carcinogens. Proc. Natl. Acad. Sci. USA, 89: 2394-2398, 1992.
12. Fimognari, C., Nusse, M., Cesari, R., Iori, R., Cantelli-Forti, G., and Hrelia, P. Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane. Carcinogenesis (Lond.), 23: 581-586, 2002.
13. Gamet-Payrastre, L., Li, P., Lumeau, S., Cassar, G., Dupont, M-A., Chevolleau, S., Gasc, N., Tulliez, J., and Tercé, F. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res., 60: 1426-1433, 2000.
14. Huang, C., Ma, W., Li, J., Hecht, S. S., and Dong, Z. Essential role of p53 in phenethyl isothiocyanate-induced apoptosis. Cancer Res., 58: 4102-4108, 1998.
15. Samaha, H. S., Kelloff, G. J., Steele, V., Rao, C. V., and Reddy, B. S. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptostic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res., 57: 1301-1305, 1997.
16. Yu, R., Mandlekar, S., Harvey, K. J., Ucker, D. S., and Kong, A-N. T. Chemopreventive isothiocyanates induce apoptosis and like protease activity. Cancer Res., 58: 402-408, 1998.
17. Conaway, C. C., Yang, Y. M., and Chung, F. L. Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans. Curr. Drug Metab., 3: 233-255, 2002.
18. Lampe, J. W., Chen, C., Li, S., Prunty, J., Grate, M. T., Meehan, D. E., Dightman, K. V. B. D. A., Feng, Z., and Potter, J. D. Modulation of human glutathione S-transferase by botanically defined vegetable diets. Cancer Epidemiol. Biomark. Prev., 9: 787-793, 2000.
19. Seow, A., Shi, C-Y., Chung, F-L., Jiao, D., Hankin, J. H., Lee, H-P., Coetzee, G. A., and Yu, M. C. Urinary total isothiocyanate (ITC) in a population-based sample of middle-aged and older Chinese in Singapore: relationship with dietary total ITC and Glutathione S-Transferase M1/T1/P1 genotypes. Cancer Epidemiol. Biomark. Prev., 7: 775-781, 1998.
20. Lin, H. J., Probst-Hensch, N. M., Louie, A. D., Kau, I. H., Witte, J. S., Ingles, S. A., Frankl, H. D., Lee, E. R., and Haile, R. W. Glutathione transferase null geonotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol. Biomark. Prev., 7: 647-652, 1998.
21. Ketterer, B. Dietary isothiocyanates as confounding factors in the molecular epidemiology of colon cancer. Cancer Epidemiol. Biomark. Prev., 7: 645-646, 1998.
22. Fares, F. A., Ge, X., Yanni, S., and Rennert, G. Dietary indole derivatives induce apoptosis in human breast cancer cells. Adv. Exp. Med. Biol., 451: 153-157, 1998.
23. Ge, X., Yannai, S., Rennert, G., Gruener, N., and Fares, F. A. 3,3-diindolylmethane induces apoptosis in human cancer cells. Biochem. Biophys. Res. Commun., 228: 153-158, 1996.
24. Hong, C., Firestone, G. L., and Bjeldanes, L. F. Bcl-2 family-mediated apoptotic effects of 3,3′-diindolylmethane (DIM) in human breast cancer cells. Biochem. Pharmacol., 63: 1085-1097, 2002.
25. Ge, X., Fares, F. A., and Yannai, S. Induction of apoptosis in MCF-7 cells by indole-3-carbinol is independent of p53 and bax. Anticancer Res., 19: 199-203, 1999.
26. Katdare, M., Osborne, M. P., and Telang, M. T. Inhibition of aberrant proliferation and induction of apoptosis in pre-neoplastic human mammary epithelial cells by natural phytochemicals. Oncol. Rep., 5: 311-315, 1998.
27. Cover, C. M., Hseih, S. J., Tran, S. H., Hallden, G., Kim, G. S., Bjeldanes, L. F., and Firestone, G. L. Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J. Biol. Chem., 273: 3838-3847, 1998.
28. Hong, C., Kim, H. A., Firestone, G. L., and Bjeldanes, L. F. 3,3′-diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21 (WAF1/CIP1) expression. Carcinogenesis, 23: 1297-1305, 2002.
29. Riby, J. E., Chang, G. H. F., Firestone, G., and Bjeldanes, L. F. Ligand-independent activation of estrogen receptor function by 3,3′-diindolylmethane in human breast cancer cells. Biochem. Pharmacol., 60: 167-177, 2000.
30. Meng, Q., Yuan, F., Boldberg, I. D., Rosen, E. M., Auborn, K., and Fan, S. Indole-3-carbinol is a negative regulator of estrogen receptor-alpha signaling in human tumor cells. J. Nutr., 130: 2927-2931, 2000.
31. Chinni, S. R. and Sarkar, F. H. Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells. Clin. Cancer Res., 8: 1228-1236, 2002.
32. Bradlow, H. L., Michnovicz, J. J., Halper, M., Miller, D. G., Wong, G. Y. C., and Osbome, M. Long-term responses of women to indole-3-carbinol or a high fiber diet. Cancer Epidemiol. Biomarkers Prev., 3: 591-595, 1994.
33. Riby, J. E., Feng, C., Chang, Y-C., Schaldach, C. M., Firestone, G. L., and Bjeldanes, L. F. The major cyclic trimeric product of indole-3-carbinol is a strong agonist of the estrogen receptor signaling pathway. Biochemistry (Mosc.), 39: 910-918, 2000.
34. Franceschi, S., Parpinel, M., LaVecchia, C., Favero, A., Telamini, R., and Negri, E. Role of different types of vegetables and fruit in the prevention of cancer of the colon, rectum, and breast. Epidemiology, 9: 338-341, 1998.
35. Graham, S., Marshall, J., Mettlin, C., Rzepka, T., Nemoto, T., and Byers, T. Diet in the epidemiology of breast cancer. Am. J. Epidemiol., 116: 68-75, 1982.
36. Katsouyanni, K., Tricholpoulos, D., Boyle, P., Xirouchaki, E., Trichopoulou, A., Lisseos, B., Vasilaros, S., and MacMahon, B. Diet and breast cancer: a case-control study in Greece. Int. J. Cancer, 38: 815-820, 1986.
37. Levi, F., Vecchia, C. L., Gulie, C., and Negri, E. Dietary factors and breast cancer risk in Vaud, Switzerland. Nutr. Cancer, 19: 327-335, 1993.
38. Zhang, S., Hunter, D., Forman, M. R., Rosner, B. A., Speizer, F. E., Colditz, G. A., Manson, J. E., Hankinson, S. E., and Willett, W. C. Dietary carotenoids and vitamin A. C, and E and risk of breast cancer. J. Natl. Cancer Inst. (Bethesda), 91: 547-556, 1999.
39. Smith-Warner, S. A., Spiegelman, D., Yaun, S-S., Adami, H-O., BEeson, W. L., Brandt, P. A. V. d., Folsom, A., Fraser, G. E., Freudenheim, J. L., Goldbohm, R. A., Graham, S., Miller, A. B., Potter, J., Rohan, T. E., Speizer, F. E., Toniolo, P., Willett, W. C., Wolk, A., Zeleniuch-Jacquotte, A., and Hunter, D. J. Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA, 285: 769-776, 2001.
40. Smith-Warner, S., Willett, W., Spiegelman, D., and Hunter, D. Reply: Brassica vegetables and breast cancer. JAMA, 285: 2977, 2001.
41. Terry, P., and Wolk, A. Brassica vegetables and breast cancer risk. JAMA, 285: 2975-2977, 2001.
42. Betz, J., and Obermeyer, W. Effects of processing on the glucosinolate content of broccoli. FASEB J., 7: 863, 1993.
43. Bible, B. B., Ju, H-Y., and Chong, C. Influence of cultivar, season, irrigation, and date of planting on thiocyanate ion content in cabbages. J. Amer. Horticul. Sci., 105: 88-91, 1980.
44. Bradfield, C. A., and Bjeldanes, L. F. High-performace liquid chromatographic analysis of anticarcinogenic indoles in Brassica oleracea. J. Agric. Food Chem., 35: 46-49, 1987.
45. Howard, L. A., Jeffrey, E. H., Wallig, M. A., and Klein, B. P. Retention of phytochemicals in fresh and processed broccoli. J. Food Sci., 62: 1098-1100, 1997.
46. Slominski, B. A., and Campbell, L. D. Formation of indole glucosinolate breakdown products in autolyzed, steamed, and cooked Brassica vegetables. J. Agric. Food Chem., 37: 1297-1302, 1989.
47. Zhang, Y., Wade, K. L., Prestera, T., and Talalay, P. Quantitative determination of isothiocyanates, dithiocarbamates, carbon disulfide, and related thiocarbonyl compounds by cyclocondensation of 1, 2-benzenedithiol. Anal. Biochem., 239: 160-167, 1996.
48. Chung, F-L., Jiao, D., Getahun, S. M., and Yu, M. C. A urinary biomarker for uptake of dietary isothiocyanates in humans. Cancer Epidemiol. Biomark. Prev., 7: 103-108, 1998.
49. London, S. J., Yuan, J-M., Chung, F-L., Gao, Y-T., Coetzee, G. A., Ross, R. K., and Yu, M. C. Isothiocyanates, glutathioneS-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet, 356: 724-729, 2000.
50. Shu, X. O., Zheng, W., Potischman, N., Brinton, L. A., Hatch, M. C., Gao, Y. T., and Fraumeni, J. F., Jr. A population-based case-control study of dietary factors and endometrial cancer in Shanghai, People's Republic of China. Am. J. Epidemiol., 137: 155-165, 1993.
51. Zheng, W., Xie, D-W., Jin, F., Cheng, J-R., Dai, Q., Wen, W-Q., Shu, X-O., and Gao, Y-T. Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol. Biomark. Prev., 9: 147-150, 2000.
52. Chinese Academy of Medical Sciences Food composition tables. Beijing: People's Health Publishing House. 1991.
53. Jiao, D., Conaway, C. C., Wang, M-H., Yang, C. S., Koehl, W., and Chung, F-L. Inhibition of N-nitrosodimethylamine demethylase in rat and human liver micosomes by isothiocyanates and their glutathione, L-cysteine, and N-acetyl-L-cysteine conjugates. Chem. Res. Toxicol., 9: 932-938, 1996.
54. Moran, J. L., Siegel, D., and Ross, D. A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proc. Natl. Acad. Sci. USA, 96: 8150-8155, 1999.
55. Arand, M., Muhlbauer, R., Hengstler, J., Jager, E., Fuchs, J., Winkler, L., and Oesch, F. A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTMI and GSTT1 polymorphisms. Ann. Biochem., 236: 184-186, 1996.
56. Zimniak, P., Nanduri, B., Pikula, S., Bandorowicz-Pikula, J., Singhal, S. S., Srivastava, S. K., Awasthi, S., and Awasthi, Y. C. Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur. J. Biochem., 224: 893-899, 1994.
57. Seow, A., Yuan, J. M., Sun, C. L., Van Den Berg, D., Lee, H. P., and Yu, M. C. Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study, Carcinogenesis (Lond.), 23: 2055-2061, 2002.
58. Hu, X., Xia, H., Srivastava, S. K., Pal, A., Awasthi, Y. C., Zimniak, P., and Singh, S. V. Catalytic efficiencies of allelic variants of human glutathione S-transferase P1-1 toward carcinogenic anti-diol epoxides of benzo[c]phenanthrene and benzo[g]chrysene. Cancer Res., 58: 5340-5343, 1998.
59. Zhao, M., Lewis, F., Gustafson, D. R., Wen, W-Q., Cerhan, J. R., and Zheng, W. No apparent association of GSTP1 A(313)G polymorphism with breast cancer risk among postmenopausal Iowa women. Cancer Epidemiol. Biomark. Prev., 10: 1301-1302, 2003.
60. Talalay, P., Fahey, J. W., Holtzclaw, W. D., Prestera, T., and Zhang, Y. Chemoprotection against cancer by Phase 2 enzyme induction. Toxicol. Lett., 82/83: 173-179, 1995.
61. Fowke, J. H., Longcope, C., and Hebert, J. R. Brassica vegetable consumption shifts estrogen metabolism in healthy postmenopausal women. Cancer Epidemiol. Biomark. Prev., 9: 773-779, 2000.
62. Leong, H., Firestone, G. L., and Bjeldanes, L. F. Cytostatic effects of 3, 3′-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-α expression. Carcinogenesis (Lond.), 22: 1809-1817, 2001.
63. Cram, E. J., Liu, B. D., Bjeldanes, L. F., and Firestone, G. L. Indole-3-carbinol inhibits CDK6 expression human MCF-7 breast cancer cells by disrupting Spl transcription factor interactions with a composite element in the CDK6 gene promoter. J. Biol. Chem., 276: 22332-22340, 2001.
64. Shapiro, T. A., Fahey, J. W., Wade, K. L., Stephenson, K. K., and Talalay, P. Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of Cruciferous vegetables. Cancer Epidemiol. Biomark. Prev., 7: 1091-1100, 1998.
65. Fowke, J. H., Chung, F-L., Shu, X-O., Dai, Q., Shintani, A., Cai, Q., Gao, Y-T., and Zheng, W. Urinary isothiocyanates and Brassica consumption among women living in Shanghai, China, submitted.
66. Chung, F-L., Jiao, D., Conaway, C. C., Smith, T. J., Yang, C. S., and Yu, M. C. Chemopreventive potential of thiol conjugates of isothiocyanates for lung cancer and a urinary biomarker of dietary isothiocyanates. J. Cell. Biochem. Suppl., 27: 76-85, 1997.
67. Kaaks, R., Riboli, E., and Estève, J. Estimating the accuracy of dietary questionnaire assessments: validation in terms of structural equation models. Stat. Med., 13: 127-142, 1994.
68. Kohlmeier, L. Future of dietary exposure assessment. Am. J. Clin. Nutr., 61: 702S-709S, 1995.
69. Kubena, K. S. Accuracy in dietary assessment: on the road to good science. J. Amer. Diet. Assoc., 100: 775-776, 2000.
70. Conaway, C. C., Getahun, S. M., Liebes, L. L., Pusateri, D. J., Topham, D. K., Botero-Omary, M., and Chung, F. L. Disposition of glucosinolates and sulforaphane in humans after ingestion of steamed and fresh broccoli. Nutr. Cancer, 38: 168-178, 2000.
71. Thompson, P. A., and Ambrosone, C. Chapter 7: Molecular epidemology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. J. Natl. Cancer Inst. Monogr., 27: 125-134, 2000.
72. Dunning, A. M., Healey, C. S., Pharoah, P. D. P., Teare, M. D., Ponder, B. A. J., and Easton, D. F. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol. Biomark. Prev., 8: 843-854, 1999.
73. Montano, M., and Katzenellenbogen, B. The quinone reductate gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens. Proc. Natl. Acad. Sci. USA, 94: 2581-2586, 1997.
74. Cavalieri, E. L., Stack, D. E., Devanesan, P. D., Todorovic, R., Dwivedy, I., Higginbotham, S., Johansson, S. L., Patil, K. D., Bross, M. L., Gooden, J. K., Ramanathan, R., Cerny, R. L., and Rogan, E. G. Molecular origin of cancer: catechol estrogen-3, 4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. USA, 94: 10937-10942, 1997.
75. McKay, J. A., Melvin, W. T., Ah-See, A. K., Ewen, S. W. B., Greenlee, W. F., Marcus, C. B., Burke, M. D., and Murray, G. I. Expression of cytochrome P450 CYP1B1 in breast cancer. FEBS Lett., 374: 270-272, 1995.
76. Cavalieri, E. L., Devanesan, P., Bosland, M. C., Badawi, A. F., and Rogan, E. G. Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: implications for estrogen-induced initiation of prostate cancer. Carcinogenesis (Lond.), 23: 329-333, 2002.
77. Lubert, R. A., Steele, V. E., Eto, I., Juliana, M. M., Kelloff, G. J., and Grubbs, C. J. Chemopreventive efficacy of anethole trithione, N-acetyl-L-cysteine, miconazole and phenethylisothiocyanate in the DMBA induced rat mammary cancer model. Int. J. Cancer, 72: 95-101, 1997.
78. Dashwood, R. H. Indole-3-carbinol: Antiarcinogen or tumor promotoer in brassica vegetables? Chem. Biol. Interact., 110: 1-5, 1998.
79. Bailey, G. S., Hendricks, J. D., Shelton, D. W., Nixon, J. E., and Pawlowski, N. Enhancement of carcinogenesis by natural anticarcinogen indole-3-carbinol. J. Natl. Cancer Inst. (Bethesda), 78: 931-934, 1987.
80. Kim, D. J., Han, B. S., Ahn, B., Hasegawa, R., Shirai, T., Ito, N., and Tsuda, K. Enhancement by indole-3-carbinol of liver and thyroid gland neoplastic development in rat medium-term multiorgan carcinogenesis model. Carcinogenesis (Lond.), 18: 377-381, 1997.
81. Hirose, M., Yamaguchi, T., Ogawa, N. K. K., Futakuchi, M., Sano, M., and Shirai, T. Strong promoting activity of phenylethyl isothiocyanate and benzyl isothiocyanate on urinary bladder carcinogenesis in F344 male rats. Int. J. Cancer. 77: 773-777, 1998.
82. Bell, M. C., Crowley-Norwick, P., Bradlow, H. L., Sepkovic, D. W., Schmidt-Grimminger, D., Howell, P., Mayeaux, E. J., Tucker, A., Turbat-Herrera, E. A., and Mathis, J. M. Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol. Oncol., 78: 123-129, 2000.
83. Bradlow, H. L., Michnovicz, J. J., Telang, N. T., and Osborne, M. P. Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis (Lond.), 12: 1571-1574, 1991.
84. Nho, C. W., and Jeffrey, E. The synergistic upregulation of Phase II detoxification enzymes by glucosinolate breakdown products in cruciferous vegetables. Toxicol. Appl. Pharmacol., 174: 146-152, 2001.
85. Kristal, A. R., and Lampe, J. W. Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence. Nutr. Cancer, 42: 1-9, 2002.
86. Michaud, D. S., Spiegelman, D., Clinton, S. K., Rimm, E. B., Willett, W. C., and Giovannucci, E. L. Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort. J. Natl. Cancer Inst. (Bethesda), 91: 605-613, 1999.